News & Updates
Filter by Specialty:
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF
Patients with nonvalvular atrial fibrillation (NVAF) and acute heart failure (AHF) see elevated levels of D-dimer, for which edoxaban may be effective, reports a recent study.
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF
19 Feb 2022
Clinician specialty does not contribute to worse outcomes in peripheral artery disease
Socioeconomic factors, but not clinician specialty, are associated with poorer outcomes among patients with peripheral artery disease (PAD), suggests a study.
Clinician specialty does not contribute to worse outcomes in peripheral artery disease
18 Feb 2022
Tirofiban may improve outcomes in LAA strokes
While additional tirofiban prior to endovascular treatment (EVT) did not appear to benefit stroke patients with large vessel occlusion (LVO), it did seem to have an advantage for those with large artery atherosclerosis (LAA), findings from the RESCUE BT trial have shown.
Tirofiban may improve outcomes in LAA strokes
16 Feb 2022
The mouth a gateway to stroke risk reduction?
In individuals who had a recent stroke or transient ischaemic attack (TIA), a trip to the dentist might just spare them from a recurrence, findings from the PREMIERS* study suggest.